Industry

Blood Pressure Monitoring Devices Market Report 2022: Growing Incidences of Blood Pressure-Related Diseases & Rise in Demand for Portable Monitoring Devices Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blood Pressure Monitoring Devices Market Research Report by Product, End-user, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Blood Pressure Monitoring Devices Market size was estimated at USD 1,692.78 million in 2021, USD 1,870.01 million in 2022, and is projected to … [Read more…]

docs24 and Intrinseque Health Form Strategic Partnership

GREENVILLE, S.C.–(BUSINESS WIRE)–docs24, a leading provider of Digital and Print Asset Management Solutions for the Clinical Research sector today announced that it has entered a strategic partnership with Intrinseque Health. Intrinseque Health provides clinical supplies and equipment to investigative sites across the globe. They do this through the implementation of robust clinical supply and equipment … [Read more…]

Global Patient Monitoring Devices Market Report 2022: Increasing Demand for Patient Monitoring Devices in Non-Hospital Settings to Drive Future Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Patient Monitoring Devices Market Research Report by Product, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Patient Monitoring Devices Market size was estimated at USD 40.08 billion in 2021, USD 45.31 billion in 2022, and is projected to grow … [Read more…]

Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care & Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Real World Evidence Solution Market Research Report by Component (Data Set and Services), Therapeutic Area, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Real World Evidence Solution Market size was estimated at … [Read more…]

Clinical Alarm Management Market Report 2022-2027: Adoption of Clinical Decision Support Tools and Centralized Monitoring Systems & High Incidence of Chronic Diseases Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Alarm Management Market Research Report by Product (Bed Alarms, EMR Integration System, and Nurse Call System), Component, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Clinical Alarm Management Market size … [Read more…]

Global Monkeypox Therapeutics Market Analysis/Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Monkeypox Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Treatment), By End User, By Region” report has been added to ResearchAndMarkets.com’s offering. Global Monkeypox therapeutics market is projected to register growth at a significant CAGR during the forecast period, 2023-2027 The market growth can be attributed to … [Read more…]

Menarini Group’s Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer

Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union Submission supported by results from the pivotal Phase 3 EMERALD study showing a statistically significant difference in the efficacy in … [Read more…]

Kyowa Kirin Receives European Commission Approval for Use of CRYSVITA®▼(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

CRYSVITA is the first approved biologic treatment in the EU for patients with TIO who cannot undergo surgical removal of tumours TOKYO, Japan–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that the European Commission (EC) approved CRYSVITA® (burosumab) for the treatment of FGF23-related hypophosphataemia in Tumour-Induced Osteomalacia (TIO) associated with phosphaturic mesenchymal … [Read more…]

Global Cleanroom Technologies Market Report 2022: Stringent Regulatory Framework in the Pharmaceutical and Biotechnology Industries is One of the Key Factors Driving Market Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Cleanroom Technologies Market with COVID-19 Impact, by Product (Fan Filter Units, HVAC, vacuum systems, disinfectants), Construction (Drywall, Hardwall, Softwall), End User (Pharmaceutical, Biotechnology, Medical device manufacturers) – Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering. The cleanroom technologies market is projected to reach USD 9.6 billion by 2026 from USD … [Read more…]

Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022

Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients Therapy recently approved in Canada under the brand name KORSUVA® Regulatory decisions in Australia and Singapore expected by the end of 2022 ST. GALLEN, Switzerland & STAMFORD, Conn.–(BUSINESS WIRE)–Vifor Fresenius Medical … [Read more…]